Harvard Bioscience Inc (HBIO) Event Aug. 04, 2022, 00:00 UTC (76% Positive) HARVARD BIOSCIENCE INC (HBIO) Reports 76% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 12:35 p.m. 🏢 Harvard Bioscience Inc (HBIO) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-1.08M $-4.45M $3.37M +75.73% 📉 Total Assets $162.34M $155.27M $7.07M +4.55% ↗️ Total Liabilities $78.94M $77.77M $1.17M +1.51% ↗️ Stockholders' Equity $78.70M N/A $78.70M +0.00% ➡️ Operating Income/Loss $-181.00K $-2.71M $2.53M +93.33% 📉 Gross Profit $31.78M $32.81M $-1.03M -3.14% ↘️ R&D Expense $5.19M $6.72M $-1.53M -22.76% 📈 Earningspersharebasic $-0.03 $-0.11 $0.08 +72.73% 📈 Earningspersharediluted $-0.03 $-0.11 $0.08 +72.73% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Harvard Bioscience Inc (HBIO) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document